AllAfrica on MSN
Patients Left Vulnerable As Diabetes Supplies Dwindle
Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...
Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...
Healthy people are injecting tiny doses of obesity medication to look and feel even better. But at what risk?
Health and Me on MSN
Eli Lilly's Popular Weight Loss Zepbound Price Goes Down, Now More Accessible
Eli Lilly has cut cash prices for its weight-loss drug Zepbound on LillyDirect, lowering monthly costs to $299–$449. The move ...
Oprah Daily on MSN
A New Form of GLP-1s Could Revolutionize Weight-Loss Treatment (Again)—And It’ll Be Available in 2026
They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.
Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results